SNY

Sanofi
48.00
0.00 (0.00%)

Period:

Draw Mode:

Volume 0
Bid Price 47.60
Ask Price 48.02
News -
Company Name Stock Ticker Symbol Market Type
Sanofi SNY NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 48.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
48.00
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0  48.00 USD

Sanofi Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 119.88B 2.50B 2.50B  48.69B  9.10B 3.57 13.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  1.78 3.99% 05/30/23 - -

more financials information »

News Sanofi

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SNY Message Board. Create One! See More Posts on SNY Message Board See More Message Board Posts

SNY Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.